Novel immune-cell targeted IL2v to deliver IL-2R signaling to tumor reactive T cells via PD-1 whilst blocking the PD-1 pathway

被引:0
|
作者
Deak, Laura Codarri [1 ]
Nicolini, Valeria [1 ]
Lauener, Laura [1 ]
Seeber, Stefan [2 ]
Richard, Marine [1 ]
Bommer, Esther [1 ]
Karagianni, Maria [1 ]
Sam, Johannes [1 ]
Schlenker, Ramona [2 ]
Mariani, Marisa [1 ]
Schwalie, Petra [3 ]
Herter, Sylvia [1 ]
Bacac, Marina [1 ]
Waldhauer, Inja [1 ]
Freimoser-Grundschober, Anne [1 ]
Teichgraber, Volker [1 ]
Klein, Christian [1 ]
Umana, Pablo [1 ]
机构
[1] Roche Innovat Ctr Zurich, Zurich, Switzerland
[2] Roche Innovat Ctr Munich, Munich, Germany
[3] Roche Innovat Ctr Basel, Basel, Switzerland
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P615
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Alopecia areata is reversed by IL-7Rα blockade via upregulation of the PD-1 signaling pathway and T cell exhaustion
    Dai, Z.
    Wang, E.
    de Jong, A.
    Christiano, A. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S17 - S17
  • [2] Effect of a novel anti-PD-1-proIL-2 bifunctional fusion protein on potent anti-tumor activity via PD-1 checkpoint inhibition and conditional IL-2R agonism
    Zhou, Harry
    Li, Zijuan
    Zhang, Feifei
    Zhang, Ze
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Alopecia areata is reversed by IL-7Rα blockade via upregulation of the PD-1 signaling pathway
    Dai, Z.
    Cerise, J.
    Chen, J.
    Petukhova, L.
    de Jong, A.
    Clynes, R.
    Christiano, A. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S9 - S9
  • [4] A novel anti-PD1-IL15 immunocytokine potentiates anti-tumor T cell activity of PD-1 checkpoint inhibition and IL-2R-beta-gamma agonism
    Lu, Dan
    Polonskaya, Zhanna
    Chang, Tzi-Pei
    Martomo, Stella
    Luna, Xenia
    Zhang, Zhikai
    Miyara, Faical
    Patel, Jeedar
    CANCER RESEARCH, 2020, 80 (16)
  • [5] A forced marriage of IL-2 and PD-1 antibody nurtures tumor-infiltrating T cells
    Holcomb, Erin A.
    Zou, Weiping
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (03):
  • [6] A novel anti-PD-1 and proIL-2 bifunctional fusion protein delivers potent anti-tumor activity via PD-1 checkpoint inhibition and tumor selective IL-2R agonism preferentially on antigen specific T cells
    Li, Zijuan
    Zhang, Feifei
    Zhang, Ze
    Zhou, Harry
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Alopecia areata reversal by il-7ra blockade via upregulation of the pd-1 signaling pathway
    Dai, Z.
    Cerise, J.
    Petukhova, L.
    Clynes, R.
    Christiano, A. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S8 - S8
  • [8] PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment
    Godfroid, Celine
    Romero, Jackeline
    Labiano, Sara
    Chuang, Chia-Hsien
    Kelemen, Andrea
    Wyss, Tania
    Roh, Vincent
    Verdeil, Gregory
    Klein, Christian
    Codarri Deak, Laura
    Umana, Pablo
    Tolstonog, Genrich, V
    Trumpfheller, Christine
    Vozenin, Marie-Catherine
    Romero, Pedro J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (01)
  • [9] IL-2/αIL-2 Complexes Massively Expand Systemic Tumor-Specific T Cells and Enhance Abscopal Responses to Radiation and αPD-1
    Onyshchenko, K.
    Luo, R.
    Firat, E.
    Niedermann, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S73 - S73
  • [10] Suppression of IL-22-Producing T Helper 22 Cells by RPE Cells via PD-L1/PD-1 Interactions
    Sugita, Sunao
    Kawazoe, Yuko
    Imai, Ayano
    Usui, Yoshihiko
    Takahashi, Masayo
    Mochizuki, Manabu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (10) : 6926 - 6933